Literature DB >> 157731

Chalazia and rosacea.

S L Lempert, M S Jenkins, S I Brown.   

Abstract

Fifty-seven percent of patients scheduled for excision of chalazia over 19 years of age and 64% of patients over the age of 29 were found to have rosacea. This compares to an incidence in our control group of 12% and 13%, respectively. Rosacea was almost twice as common in patients with recurrent chalazia as in those with only one occurrence.

Entities:  

Mesh:

Year:  1979        PMID: 157731     DOI: 10.1001/archopht.1979.01020020220006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Time-dependent degenerative transformations in the lipidome of chalazia.

Authors:  Jadwiga C Wojtowicz; Igor A Butovich; Anne McMahon; Robert N Hogan; Kamel M Itani; Ronald Mancini; Mike Molai; Emily Linsenbardt
Journal:  Exp Eye Res       Date:  2014-08-19       Impact factor: 3.467

2.  Botulinum toxin A injection for primary and recurrent chalazia.

Authors:  Tamara Knezevic; Renata Ivekovic; Jasna Pavicic Astalos; Katia Novak Laus; Zdravko Mandic; Aljosa Matejcic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-11       Impact factor: 3.117

3.  [Ocular rosacea].

Authors:  B Sobolewska; M Zierhut
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

Review 4.  Rosacea and atopic dermatitis. Two common oculocutaneous disorders.

Authors:  Benjamin Barankin; Lyn Guenther
Journal:  Can Fam Physician       Date:  2002-04       Impact factor: 3.275

5.  Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea.

Authors:  D V Seal; P Wright; L Ficker; K Hagan; M Troski; P Menday
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

6.  Manifestations of ocular rosacea in females with dark skin types.

Authors:  Amal O Al-Balbeesi; Eman A Almukhadeb; Mona R Halawani; Ghada A Bin Saif; Samir M Al Mansouri
Journal:  Saudi J Ophthalmol       Date:  2019-01-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.